What should I Know Regarding Pregnancy, Nursing and Administering Simlandi(CF) Autoinjector 40 Mg/0.4 Ml Subcutaneous Auto-Injector Kit Tumor Necrosis Factor Inhibiting Agents to Children or the Elderly?
If you are PREGNANT
- Requires a Risk/Benefit Assessment:
If you are NURSING
- Precaution: LIMITED DATA SUGGEST LOW LEVELS EXCRETED; INFANT ABSORPTION UNLIKELY
If you are an adult over 60
- Management or Monitoring Precaution: General-Patients older than 65 years of age are at increased risk for severe infection and malignancy.
Giving Simlandi(CF) Autoinjector 40 Mg/0.4 Ml Subcutaneous Auto-Injector Kit Tumor Necrosis Factor Inhibiting Agents to a child under 12
- Severe Precaution: No safety and efficacy established age <2 years. Possible malignancy, lymphoma, hepatosplenic T-cell lymphoma risk. Risk of neutropenia, streptococcal pharyngitis, appendicitis, herpes zoster and simplex, myositis, and metrorrhagia.
- Management or Monitoring Precaution: Higher incidence of infection in pediatrics. Monitor for lymphoma, malignancy, leukemia, appendicitis and rare report of hepatosplenic T-cell lymphoma.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.